HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 26.91
-0.52 (-1.90%)
Apr 17, 2026, 4:00 PM EDT
HitGen Market Cap
HitGen has a market cap or net worth of 10.73 billion as of April 20, 2026. Its market cap has increased by 74.87% in one year.
Market Cap
10.73B
Enterprise Value
9.98B
Revenue
525.57M
Ranking
n/a
PE Ratio
95.93
Stock Price
26.91
Market Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 10.73B, a decrease of -43.12%. That is a compound annual growth rate of -8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 10.73B | 14.54% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Chengdu Easton Biopharmaceuticals | 11.66B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.51B |
| Chongqing Genrix Biopharmaceutical | 11.41B |
| Aurisco Pharmaceutical | 11.19B |
| Beijing Hotgen Biotech | 10.92B |
| Jiangxi Fushine Pharmaceutical | 10.15B |